News Formal

Novartis to acquire UK-based ocular gene therapy company | Malay Mail

  • 📰 malaymail
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 86%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

GENEVA, Dec 22 — Swiss pharmaceutical giant Novartis said today it was to acquire a UK-based biotech company developing gene therapies for eye diseases called Gyroscope Therapeutics. Novartis will make an upfront payment of US$800 million (RM3.3 billion) to acquire all of the outstanding share...

GENEVA, Dec 22 — Swiss pharmaceutical giant Novartis said today it was to acquire a UK-based biotech company developing gene therapies for eye diseases called Gyroscope Therapeutics.

Novartis will make an upfront payment of US$800 million to acquire all of the outstanding share capital of the company, as well as potential additional milestone payments of up to US$700 million, it said in a statement. Gyroscope Therapeutics has been developing a one-time gene therapy to treat an age-related condition known as geographic atrophy, which causes lesions on the retina and can cause blindness, it said.Novartis said the transaction’s closing was still subject to regulatory approvals. — AFP

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 1. in SE

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

European stocks open on mixed note | Malay MailBERLIN, Dec 22 — European equities opened mixed today, with London dampened by news of a sharper-than-expected economic slowdown in the third quarter. The British capital’s benchmark FTSE 100 index of major blue-chip companies dipped 0.1 per cent to 7,287.19 points, compared with yesterday’s...
Källa: malaymail - 🏆 1. / 86 Läs mer »